Abstract:Objective To investigate microRNA-363 (miR-363) regulation in proliferation and migration of human umbilical vascular smooth muscle cells (VSMCs) and explore the possible mechanisms of miR-363 affecting the biological behavior of VSMCs.Methods Primary cultured human umbilical VSMCs were treated with 30 μg/L of platelet derived growth factor BB (PDGF-BB) to induce phenotypic switch,and miR-363 expression was quantified by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR).VSMCs were transfected with miR-363 mimics and miR-NC for negative control,VSMCs proliferation and migration in both groups were evaluated using cell counting kit-8 assays (CCK-8) assay and Transwell migration assay,respectively; phenotypic proteins of α-SMA and Calponin-1 were detected by Western blotting analysis.Comparisons were made between the two groups.Target gene of miR-363 was predicted using bioinformatics analysis,and confirmed by Western blotting analysis.Results VSMCs switched to contractile phenotype 72 hours after they were co-cultured with PDGF-BB.Contractile phenotype protein of α-SMA was down-regulated by 28％ (P ＜0.05) ; the expression of miR-363 was down-regulated by 70％ (P ＜ 0.01).Compared to miR-NC group,significant inhibition of proliferation and migration were observed in miR-363 over-expressed VSMCs,by 32％ and 30％,respectively at 72 hours (P ＜ 0.05).Kruppel-like factor 4 (Klf4),the target gene of miR-363,was down-regulated by 19％ (P ＜ 0.05),52％ (P ＜ 0.01) and 37％ (P ＜ 0.01),respectively 24,48 and 72 hours after VSMCs were transfected with miR-363 ; however,the expression of α-SMA and Calponin-1 were not significant.Conclusion Our results suggest that up-regulation of miR-363 may inhibit proliferation and migration of human VSMCs,and these effects may be achieved partly through targeting the KLF4 expression.

Mir-145-5p Inhibits Vascular Smooth Muscle Cells (vsmcs) Proliferation and Migration by Dysregulating the Transforming Growth Factor-b Signaling Cascade.

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

Mir-145 Inhibits the Proliferation and Migration of Vascular Smooth Muscle Cells by Regulating Autophagy.

MiR-340 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting von Hippel–Lindau Tumor Suppressor Gene

miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins

MicroRNA-638 is Highly Expressed in Human Vascular Smooth Muscle Cells and Inhibits PDGF-BB-induced Cell Proliferation and Migration Through Targeting Orphan Nuclear Receptor NOR1.

MiR-411-5p Promotes Vascular Smooth Muscle Cell Phenotype Switch by Inhibiting Expression of Calmodulin Regulated Spectrin-Associated Protein-1

MicroRNA Mir145 Regulates TGFBR2 Expression and Matrix Synthesis in Vascular Smooth Muscle Cells.

Effects of microRNA-145 on proliferation and migration of rat arterial vascular smooth muscle cells through targeting MMP-9

MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1.

MicroRNA-541 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting IRF7.

Mir-503 Inhibits Platelet-Derived Growth Factor-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation and Migration Through Targeting the Insulin Receptor

MiR-223/NFAT5 Signaling Suppresses Arterial Smooth Muscle Cell Proliferation and Motility in Vitro.

Mir-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

MicroRNA-363 Regulation in Proliferation and Migration of Human Umbilical Vascular Smooth Muscle Cells

Downregulation of Mir‑142‑5p Inhibits Human Aortic Smooth Muscle Cell Proliferation and Migration by Targeting MKL2.

A Necessary Role of Mir-221 and Mir-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia.

miRNA-145 inhibits VSMC proliferation by targeting CD40

miR-654-5p suppresses migration and proliferation of vascular smooth muscle cells by targeting ADAMTS-7.